ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Quality of Life, Use of Topical Medications and Socio-economic Data in Hand Eczema: A Swedish Nationwide Survey

doi: 10.2340/00015555-1111

Abstract:

Hand eczema is common and has an adverse impact on the lives of patients. There is a need for population-based surveys on the pharmacoepidemiological aspects, quality of life and impact of socioeconomic factors in hand eczema. The aim of this cross-sectional study was to investigate these factors. A questionnaire-based nationwide survey of health was performed, including questions on hand eczema, use of pharmaceuticals and socioeconomic factors. Quality of life was estimated with the generic instrument Short Form 36 (SF-36). The questionnaire was sent to 7,985 persons (age range 18–84 years), response rate 61.1% (n = 4,875). The 1-year prevalence of hand eczema in the study population was 7.5%. In this group, quality of life was lower. All dimensions of SF-36 were affected, most markedly general health and those dimensions reporting on mental health. In the group with self-reported hand eczema, 51% reported using topical pharmaceuticals. Hand eczema was more common among women (9.1%, n = 2,630) than among men (5.6%, n = 2,245) and in the age group below 65 years (8.5%, n = 3,274) compared with those aged 65 years and over (4.3%, n = 1,151). This survey clearly demonstrates the impact of hand eczema on several dimensions of life and also highlights age, gender and socioeconomic differences.

Authors:

Kerstin Bingefors, Magnus Lindberg, Dag Isacson

References

  1. Stenberg B, Meding B, Svensson Å. Dermatology in public health – a model for surveillance of common skin diseases. Scand J Public Health 2010; 38: 368–374. [CrossRef]
  2. Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009; 161: 397–403. [CrossRef]
  3. Meding B, Järvholm B. Hand eczema in Swedish adults – changes in prevalence between 1983 and 1996. J Invest Dermatol 2002; 118: 719–723. [CrossRef]
  4. Montnémery P, Nihlén U, Löfdahl CG, Nyberg P, Svensson Å. Prevalence of hand eczema in an adult Swedish population and the relationship to risk occupation and smoking. Acta Derm Venereol 2005; 85: 429–432. [CrossRef]
  5. Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population – prevalence and main findings. Contact Dermatitis 2010; 62: 75–87. [CrossRef]
  6. Meding B. Differences between the sexes with regard to work-related skin diseases. Contact Dermatitis 2000; 43: 65–71. [CrossRef]
  7. Meding B, Wrangsjö K, Järvholm B. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005; 152: 975–980. [CrossRef]
  8. Veien NK, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis II. Contact Dermatitis 2008; 58: 335–339. [CrossRef]
  9. Keegel T, Moyle M, Dharmage S, Frowen K, Nixon R. The epidemiology of occupational contact dermatitis (1990–2007); a systematic review. Int J Dermatol 2009; 48: 571–578. [CrossRef]
  10. Diepgen T, Kanerva L. Occupational skin diseases. Eur J Dermatol 2006; 16: 324–330. [CrossRef]
  11. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Prognosis of occupational hand eczema: a follow-up study. Arch Dermatol 2006; 142: 305–311. [CrossRef]
  12. Dalgard F, Svensson Å, Holm JO, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Invest Dermatol Symp Proc 2004; 9: 120–125. [CrossRef]
  13. Chen CS, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 2004; 9: 160–168. [CrossRef]
  14. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al. The burden of skin diseases: 2004 joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2007; 55: 490–500. [CrossRef]
  15. Wallenhammar LM, Nyfjäll M, Lindberg M, Meding B. Health-related quality of life and hand eczema – a comparison of two instruments, including factor analysis. J Invest Dermatol 2004; 122: 1381–1389. [CrossRef]
  16. Agner T, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Frosch P, et al. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis 2008; 59: 43–47. [CrossRef]
  17. Hald M, Berg ND, Elberling J, Johansen JD. Medical consultations in relation to severity of hand eczema in the general population. Br J Dermatol 2008; 158: 773–777. [CrossRef]
  18. Meding B, Swanbeck G. Consequences of having hand eczema. Contact Dermatitis 1990; 23: 6–14. [CrossRef]
  19. Noiesen E, Munck MD, Larsen K, Hoyen M, Agner T. Gender differences in topical treatment of allergic contact dermatitis. Acta Derm Venereol 2009; 89: 79–81. [CrossRef]
  20. Undersökning om hälsa. Rapport om en undersökning genomförd november 2004–januari 2005. [Survey on health, report on a survey conducted November 2004–January 2005]. Statistics Sweden, Örebro; 2005 (in Swedish). [CrossRef]
  21. Lundström S, Särndal CE. Calibration as a standard method for treatment of nonresponse. J Official Stat 1999; 15: 305–327. [CrossRef]
  22. Living conditions. Appendix 13. Technical report for 1984–85, 1986–87 and 1988–89 years. Statistics Sweden, Örebro; 1991. [CrossRef]
  23. Living conditions. Report no 76. Health and medical care 1980–1989. Statistics Sweden, Örebro; 1992. [CrossRef]
  24. Thorslund M, Wärneryd B. Methodological research in the Swedish surveys of living conditions. Problems of measurements and data collection. Soc Ind Res 1985; 16: 77–95. [CrossRef]
  25. Meding B, Barregaard L. Validity of self-reports of hand eczema. Contact Dermatitis 2001; 45: 99–103. [CrossRef]
  26. Ware J, Kosinski M, Sherbourne C. SF-36 Physical and Mental Health Summary Scales: a user’s manual. Boston, MA: New England Medical Center; 1994. [CrossRef]
  27. Ware J, Sherbourne C. The MOS 36 item short form health survey (SF-36). Med Care 1992; 30: 473–483. [CrossRef]
  28. Ware J, Snow K, Kosinski M, Sherbourne C. SF-36 Health survey manual and interpretation guide. Boston, MA: New England Medical Center; 1993. [CrossRef]
  29. SAS Institute Inc. The SAS system for Windows, Release 8.02. [1999–2001]. Cary, NC: SAS Institute Inc.; 2001. [CrossRef]
  30. Agner T, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Frosch P, et al. Contact sensitisation in hand eczema patients – relation to subdiagnosis, severity and quality of life: a multi-centre study. Contact Dermatitis 2009; 61: 291–296. [CrossRef]
  31. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch PM, et al. Hand eczema classification: a cross-sectional, multicenter study of the aetiology and morphology of hand eczema. Br J Dermatol 2008; 160: 353–358. [CrossRef]
  32. Weistenhöfer W, Baumeister T, Drexler H, Kutting B. An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence-based medicine. Br J Dermatol 2010; 162: 239–250. [CrossRef]
  33. Bingefors K, Lindberg M, Isacsson D. Self-reported dermatological problems and use of prescriped topical drugs correlate with decreased quality of life: an epidemiological survey. Br J Dermatol 2002; 147: 285–290. [CrossRef]
  34. Diepgen T, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57: 203–210. [CrossRef]
  35. Meding B, Lantto R, Lindahl G, Wrangsjö K, Bengtsson B. Occupational skin disease in Sweden – a 12-year follow-up. Contact Dermatitis 2005; 53: 308–313. [CrossRef]
  36. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997–1035. [CrossRef]
  37. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726–2739. [CrossRef]
  38. Chen SC. Dermatology quality of life instruments: sorting out the quagmire. J Invest Dermatol 2007; 127: 2695–2696. [CrossRef]
  39. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305–314. [CrossRef]
  40. McCombs K, Chen CL. Patient preference quality of life measures in dermatology. Dermatol Ther 2007; 20: 102–109. [CrossRef]
  41. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006; 54: 106–111. [CrossRef]
  42. Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the litterature. Br J Dermatol 2003; 149: 452–456. [CrossRef]
  43. Niemeier V, Nippesen M, Kupfer J, Schill WB, Gieler U. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol 2002; 146: 1031–1037. [CrossRef]
  44. Zachariae R, Zachariae C, Ibsen HH, Mortensen JT, Wulf HC. Psychological symptoms and quality of life of dermatoilogy outpatients and hospitalized dermatology patients. Acta Derm Venereol 2004; 84: 205–212. [CrossRef]
  45. Bingefors K, Isacson D. Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain – a gender perspective. Eur J Pain 2004; 8: 435–450. [CrossRef]

Share with your friends





Actions


Abstract

Full text

PDF

Supplementary


Table S1

Print information


Volume 91, Issue 4

DOI: 10.2340/00015555-1111

Pages: 452-458

View at PubMed